Skip to Main Content

Paper Details

MCB-613 exploits a collateral sensitivity in drug resistant <i>EGFR</i>-mutant non-small cell lung cancer through covalent inhibition of KEAP1.
bioRxiv
0
2023
Author NameAffiliation
Christopher F BassilDuke University
Gray R AndersonDuke University
Peter S WinterDuke University
Jacob P HojDuke University
Katherine R SingletonDuke University
Patrick AubergerUniversite Cote d'Azur, INSERM
Alexandre PuissantUniversite de Paris, INSERM, CNRS
Kris C WoodDuke University
  • 1 - 8

Datasets

Release 1.2